Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
BackgroundThe autoantibody to myelin oligodendrocyte glycoprotein (MOG), a component of the central nervous system myelin, has been identified in a subset of demyelinating diseases. However, there is no convincing evidence to support the direct pathogenic contribution of this autoantibody.ObjectiveT...
Main Authors: | Kuniko Kohyama, Hiroya Nishida, Kimihiko Kaneko, Tatsuro Misu, Ichiro Nakashima, Hiroshi Sakuma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2023.1014071/full |
Similar Items
-
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
by: Patrick Peschl, et al.
Published: (2017-05-01) -
Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
by: Jin Myoung Seok, et al.
Published: (2023-06-01) -
Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report
by: Jan Kolcava, et al.
Published: (2022-08-01) -
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
by: Mader Simone, et al.
Published: (2011-12-01) -
Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder
by: Yunjie Li, et al.
Published: (2022-09-01)